We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3351
Arcutis Biotherapeutics
ARQT
$3.66B
| $219 | ﹤0.01% |
14
-14
| -50% | -$197 |
2024 Q4
1 quarter
|
|
3352
Prime Medicine
PRME
$655M
| $219 | ﹤0.01% |
+110
| New | +$281 |
2025 Q1
0 quarters
|
|
3353
DELISTED
American Express Global Business Travel
GBTG
| $218 | ﹤0.01% |
+30
| New | +$253 |
2025 Q1
0 quarters
|
|
|
SILA
3354
DELISTED
Sila Realty Trust
SILA
| $214 | ﹤0.01% |
+8
| New | +$200 |
2025 Q1
0 quarters
|
|
3355
MediaAlpha
MAX
$619M
| $213 | ﹤0.01% |
23
+6
| +35% | +$64 |
2024 Q4
1 quarter
|
|
3356
Hovnanian Enterprises
HOV
$602M
| $209 | ﹤0.01% |
2
| – | – |
2023 Q3
6 quarters
|
|
3357
Evolv Technologies
EVLV
$757M
| $206 | ﹤0.01% |
+66
| New | +$232 |
2025 Q1
0 quarters
|
|
3358
Oruka Therapeutics
ORKA
$4.89B
| $205 | ﹤0.01% |
20
| – | – |
2021 Q3
14 quarters
|
|
3359
Lands' End
LE
$304M
| $204 | ﹤0.01% |
+20
| New | +$238 |
2025 Q1
0 quarters
|
|
3360
Forward Air
FWRD
$535M
| $201 | ﹤0.01% |
10
-65
| -87% | -$1.79K |
2016 Q4
33 quarters
|
|
3361
Altimmune
ALT
$459M
| $200 | ﹤0.01% |
40
| – | – |
2021 Q1
16 quarters
|
|
3362
Disc Medicine
IRON
$2.17B
| $199 | ﹤0.01% |
4
+3
| +300% | +$167 |
2024 Q4
1 quarter
|
|
3363
KraneShares Global Carbon Strategy ETF
KRBN
$137M
| $198 | ﹤0.01% |
7
| – | – |
2023 Q2
7 quarters
|
|
3364
DELISTED
Aeva Technologies Warrants
AEVAW
| $198 | ﹤0.01% |
2,500
| – | – |
2021 Q4
13 quarters
|
|
3365
Enliven Therapeutics
ELVN
$2.88B
| $197 | ﹤0.01% |
10
+6
| +150% | +$129 |
2024 Q4
1 quarter
|
|
3366
Central Garden & Pet Co Class A
CENTA
$2.26B
| $196 | ﹤0.01% |
6
-7
| -54% | -$222 |
2024 Q1
4 quarters
|
|
3367
V2X
VVX
$2.15B
| $196 | ﹤0.01% |
4
-3
| -43% | -$147 |
2024 Q4
1 quarter
|
|
3368
Relay Therapeutics
RLAY
$3.79B
| $194 | ﹤0.01% |
+74
| New | +$290 |
2025 Q1
0 quarters
|
|
3369
Hillman Solutions
HLMN
$1.41B
| $193 | ﹤0.01% |
22
-33
| -60% | -$321 |
2024 Q3
2 quarters
|
|
3370
Healthcare Services Group
HCSG
$1.47B
| $192 | ﹤0.01% |
19
| – | – |
2016 Q4
33 quarters
|
|
3371
Deluxe
DLX
$1.05B
| $190 | ﹤0.01% |
12
-20
| -63% | -$379 |
2023 Q2
7 quarters
|
|
3372
FTAI Infrastructure
FIP
$303M
| $190 | ﹤0.01% |
42
+30
| +250% | +$187 |
2024 Q4
1 quarter
|
|
3373
LG Display
LPL
$2.66B
| $190 | ﹤0.01% |
61
| – | – |
2021 Q2
15 quarters
|
|
3374
Janux Therapeutics
JANX
$1.06B
| $189 | ﹤0.01% |
7
+5
| +250% | +$188 |
2024 Q3
2 quarters
|
|
3375
St. Joe Company
JOE
$3.86B
| $188 | ﹤0.01% |
4
| – | – |
2024 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.